Windlas Biotech Gets CDSCO Panel Nod To study Bisoprolol Fumarate, Telmisartan, Chlorthalidone FDC Dr. Divya Colin26 March 2025 6:15 PM ISTNew Delhi: Windlas Biotech has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Servier Introduces Cosyrel: A Novel SPC for Hypertension and Post-MI Care Deeksha Bhandari16 Jan 2025 2:59 PM ISTServier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name Cosyrel, which is...
Bisoprolol, Telmisartan, Chlorthalidone FDC: CDSCO asks Windlas Biotech to submit new BE protocol Dr. Divya Colin10 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined Windlas Biotech to...
Akums Gets CDSCO panel Nod To Manufacture, Market Bisoprolol Fumarate Dr. Divya Colin26 July 2023 6:00 PM ISTNew Delhi: Considering the request of the drug major Akum Pharmaceuticals for a bioequivalence study (BE) and clinical trial waiver, the Subject...
Eris Lifesciences Gets CDSCO Panel Nod To Study FDC Dapagliflozin plus Bisoprolol Fumarate Dr. Divya Colin2 July 2023 6:00 PM ISTNew Delhi: Granting the waiver of the bioequivalence study, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug Dr. Divya Colin1 Oct 2022 5:00 PM ISTNew Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Glenmark bags USFDA nod for generic version of Ziac Tablets Ruchika Sharma27 Jan 2022 10:45 AM ISTMumbai: Glenmark Pharmaceuticals Inc., USA has received final approval from the United States Food & Drug Administration (USFDA) for Bisoprolol...
